Cargando…
Genetic testing for familial hyperparathyroidism: clinical-genetic profile in a Mediterranean cohort
BACKGROUND: Approximately 10% of primary hyperparathyroidism cases are hereditary, due to germline mutations in certain genes. Although clinically relevant, a systematized genetic diagnosis is missing due to a lack of firm evidence regarding individuals to test and which genes to evaluate. METHODS:...
Autores principales: | Mazarico-Altisent, Isabel, Capel, Ismael, Baena, Neus, Bella-Cueto, Maria Rosa, Barcons, Santi, Guirao, Xavier, Pareja, Rocío, Muntean, Andreea, Arsentales, Valeria, Caixàs, Assumpta, Rigla, Mercedes |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10558207/ https://www.ncbi.nlm.nih.gov/pubmed/37810884 http://dx.doi.org/10.3389/fendo.2023.1244361 |
Ejemplares similares
-
Novel germline variants of CDKN1B and CDKN2C identified during screening for familial primary hyperparathyroidism
por: Mazarico-Altisent, I., et al.
Publicado: (2022) -
Naltrexone sustained-release/bupropion sustained-release for the management of obesity: review of the data to date
por: Caixàs, Assumpta, et al.
Publicado: (2014) -
Simultaneous onset of type 1 diabetes mellitus and silent thyroiditis under durvalumab treatment
por: León Mengíbar, Jose, et al.
Publicado: (2019) -
Response to Initial Therapy of Differentiated Thyroid Cancer Predicts the Long-Term Outcome Better than Classical Risk Stratification Systems
por: Cano-Palomares, Albert, et al.
Publicado: (2014) -
Takotsubo cardiomyopathy in amiodarone-induced hyperthyroidism
por: Capel, Ismael, et al.
Publicado: (2017)